Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0001562180-24-006014

Chief Executive Officer sold 100 shares at $15.00 ($1,500)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Simpson Curran · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-08-01 Sale : show line 1 in the form 10b5-1 −100 $15.00 $1,500 170,037 D
Open-market sales · 100 sh · avg $15.00 · $1,500
Loading xslF345X05/primarydocument.xml…